When people learn there's a pill that's been available for many years, that will keep them safe from HIV. They are surprised and may want to know more. And when people are surprised and even upset, we know we need to do more.
COVID-19 has changed the way society operates in countless ways. During our inaugural podcast, our team of addiction specialists and HIV providers, Drs.
This webinar companion guide provides information for the January 2021 Strengthening Systems of Care: Supporting People with HIV and Opioid Use Disorder following Incarceration webinar.
This Advisory offers guidance to providers and administrators in SUD treatment programs on screening clients for hepatitis A, hepatitis B, and hepatitis C infections, as well as action steps for the treatment and support of clients with a viral hepatitis infection and a SUD.
This Advisory highlights strategies and considerations for substance use disorder (SUD) treatment providers to integrate HIV services into their practice and effectively engage people with HIV in SUD treatment.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).
This document contains slides for the September 2020 Models of Integrated Care for HIV and Opioid Use Disorder: Considerations for Community and Clinical Settings webinar.
